Brainsway Ltd. (NASDAQ:BWAY) saw its stock pop 5% in premarket trading Thursday after securing a key FDA label expansion for its Deep Transcranial Magnetic Stimulation (Deep TMS) system, clearing the ...
Credit: BrainsWay. The outpatient procedure provides noninvasive magnetic stimulation through a cushioned helmet to induce electrical currents in localized regions of the prefrontal cortex. Real-world ...
NEW YORK, March 13, 2026 /PRNewswire/ -- Radial today announced publication of a landmark study showing accelerated Deep TMS can treat depression in six days instead of months. The research evaluated ...
Unlike commonly used oral antidepressants (often known as selective serotonin reuptake inhibitors or SSRIs), ketamine works through a different mechanism. It targets glutamate pathways in the brain, ...
Moment of Clarity has published a new educational resource titled “How Deep TMS Therapy Works,” providing a comprehensive overview of transcranial magnetic stimulation (TMS) and its emerging role in ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
BURLINGTON, Mass. and JERUSALEM, March 04, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) unveiled new clinical data showing a significantly faster, noninvasive way to treat depression ...
BrainsWay Ltd. BWAY recently secured FDA clearance for an accelerated treatment protocol using its Deep Transcranial Magnetic Stimulation (TMS) system. The approval allows providers to treat patients ...
Please provide your email address to receive an email when new articles are posted on . Ketamine provides rapid action, and transcranial magnetic stimulation offers durability. Both treatments involve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results